| # | Drug | Count |
|---|---|---|
| 0 | TACROLIMUS | 93 |
| 1 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 88 |
| 2 | TACROLIMUS OINTMENT 0.1% | 88 |
| 3 | MYCOPHENOLATE MOFETIL | 71 |
| 4 | PREDNISOLONE | 49 |
| 5 | PREDNISOLONE ORAL | 49 |
| 6 | PREDNISOLONE ORAL SOLUTION | 49 |
| 7 | GANCICLOVIR SODIUM | 40 |
| 8 | METHYLPREDNISOLONE | 40 |
| 9 | GANCICLOVIR | 38 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | FOSCARNET SODIUM | 16 | 0.0040 |
| 1 | GANCICLOVIR SODIUM | 40 | 0.0037 |
| 2 | EPCORITAMAB-BYSP | 4 | 0.0030 |
| 3 | OLOPATADINE HCL | 1 | 0.0027 |
| 4 | VALGANCICLOVIR | 35 | 0.0018 |
| 5 | CIDOFOVIR ANHYDROUS | 2 | 0.0014 |
| 6 | TALIMOGENE LAHERPAREPVEC | 2 | 0.0013 |
| 7 | EVEROLIMUS TABLETS | 21 | 0.0012 |
| 8 | LETERMOVIR | 4 | 0.0012 |
| 9 | NAFCILLIN SODIUM | 1 | 0.0011 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] | 47 | 0.0021 |
| 1 | Bispecific CD20-directed CD3 T Cell Engager [EPC] | 5 | 0.0012 |
| 2 | Cytomegalovirus DNA Terminase Complex Inhibitor [EPC] | 4 | 0.0012 |
| 3 | Osmotic Diuretic [EPC] | 3 | 0.0006 |
| 4 | Antimetabolite Immunosuppressant [EPC] | 11 | 0.0005 |
| 5 | CD52-directed Cytolytic Antibody [EPC] | 9 | 0.0005 |
| 6 | Nucleoside Analog Antiviral [EPC] | 39 | 0.0005 |
| 7 | CD22-directed Immunoconjugate [EPC] | 1 | 0.0003 |
| 8 | Rifamycin Antimycobacterial [EPC] | 1 | 0.0003 |
| 9 | CD33-directed Immunoconjugate [EPC] | 1 | 0.0003 |